Back to 
WOLVERINE TRADING, LLC
WOLVERINE TRADING, LLC
AMLX
Showing 0 of 2 quarters
Position history for WOLVERINE TRADING, LLC's holdings in AMYLYX PHARMACEUTICALS INC
No. Wolverine Trading exited its AMLX (Amylyx Pharmaceuticals) position in Q2 2024. Its Q1 2024 13F listed 11,571 shares worth $32,862. Wolverine Trading first reported AMLX in Q1 2024 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.